Updated time: 2020-09-28 19:00:05
28A-1090908
2020-09-28
USP Pending
So far, there is no effective treatment or preventive vaccine to contain this devastating infectious disease. Because the trimeric spike protein on the viral surface is highly glycosylated and evolved to more than 65,000, posing a major challenge in the development of antibodies and vaccines with broadly protective effects. Development of alternative treatments such as small-molecule therapeutics, especially from the existing drugs and herb medicines, is therefore an attractive option. A cell-based infection assay screened more than 3,000 existing drugs and many herb medicines/supplements at the concentrations ranging from 0.1 uM to 10 uM . This invention has identified 16 existing drugs and several herb medicines/supplements well able to reduce the SARS-CoV-2 infectivity and replication when their extracts were diluted up to 16—960 folds. Some of their activities were verified by inhibiting protease and RNA-dependent polymerase and some of them showed strong protection of mice challenging with SARS-CoV-2 virus.
- Drugs show both in vitro and in vivo anti-virus activities.
- The compositions and formula of water extraction of herb medicine are keys for anti-virus activity.
- These medicine can be used as major therapy or adjuvant therapy for anti-SARS-CoV-2 virus treatment.
- High safety.
- Treatment of SARS-CoV-2 infection.
- As adjuvant therapy for the treatment of SARS-CoV-2 infection.
Shang-Cheng Hung, Chi-Huey Wong, Jia-Tsrong Jan, Ting-Jen Cheng, Che Ma, Rong-Jie Chein, Wen-Bin Yang, Ying-Ta Wu, Pi-Hui Liang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Drug repurposing and Herb Medicines for anti-SARS-CoV-2 Infection thereof